Home » diagnostic » Page 4
Tag:

diagnostic

Health

Autism & Nutrient Deficits: Vitamin D & Iron Link?

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

Beyond Picky Eating: Singapore Study Reveals Hidden Nutrient Deficiencies in Children with Autism

(Hook: Starts with a relatable pain point for parents and immediately introduces the surprising finding)

As any parent of a child with autism knows, mealtimes can be…challenging. But what if the struggle wasn’t just about getting your child to try new foods? New research out of Singapore suggests that nutrient deficiencies, particularly in Vitamin D and Iron, are surprisingly common in children with autism, and aren’t necessarily linked to picky eating. This finding underscores a critical need for routine nutritional screening, offering a proactive step towards supporting the health and development of children on the spectrum.

(Keyword: Autism & Nutrient Deficiency – strategically placed early)

The study, published in the journal Nutrients, examined the medical records of 241 children diagnosed with Autism Spectrum Disorder (ASD) in Singapore. Researchers aimed to understand the prevalence of Vitamin D and Iron deficiencies within this population, a crucial area of investigation given the vital roles these nutrients play in bone health, immune function, and cognitive development.

What Did the Study Find?

The results revealed a significant portion of children with ASD were lacking essential nutrients:

  • Vitamin D Deficiency: 36.5% of 222 participants tested showed insufficient levels.
  • Iron Deficiency: 37.7% of 236 participants tested were iron deficient.
  • Iron Deficiency Anemia: A concerning 15.6% of 122 children with complete blood count data were diagnosed with iron deficiency anemia.

(Addressing a key surprise from the source material)

Perhaps the most surprising finding? Picky eating wasn’t a reliable predictor of these deficiencies. This challenges the common assumption that selective eating habits are the primary driver of nutritional problems in children with ASD.

Who is at Risk?

The study identified specific factors that increased the likelihood of deficiencies:

  • Older Age: Older children were more likely to be deficient in both Vitamin D and Iron, and particularly at risk for iron deficiency anemia.
  • Ethnicity: Non-Chinese children showed a significantly higher risk of Vitamin D insufficiency/deficiency.

These findings highlight the importance of considering age and ethnicity when assessing the nutritional needs of children with ASD. Singapore’s diverse population provided a unique context for this research, filling a gap in previous studies which largely focused on Caucasian populations.

Why This Matters: The Importance of Routine Screening

Children with ASD often exhibit sensory sensitivities and rigid food preferences, leading to limited dietary variety. While these behaviors are well-documented, this study demonstrates that relying solely on observation of eating habits isn’t enough.

“These findings underscore and support the inclusion of frequent nutritional screening as a part of an ASD child’s routine healthcare,” explains the study. Early identification of deficiencies allows for timely intervention, potentially mitigating developmental delays and improving overall health.

(Acknowledging limitations – builds trust and demonstrates journalistic integrity)

Researchers caution that the study’s findings should be interpreted with some consideration, as only 23.8% of eligible children underwent testing, potentially introducing sampling bias. However, the results still provide valuable insights into the nutritional landscape of children with ASD in a multi-ethnic Asian setting.

What is Autism Spectrum Disorder (ASD)?

Autism Spectrum Disorder is a neurobiological developmental condition characterized by challenges in social communication and repetitive behaviors. Understanding the unique needs of children with ASD, including their nutritional requirements, is crucial for providing comprehensive care.

(Call to Action/Concluding Thought – encourages further engagement)

This research emphasizes that a proactive approach to nutrition is vital for children with autism. Parents and caregivers should discuss routine nutritional screening with their pediatrician to ensure their child receives the support they need to thrive.

SEO Notes & Strategy:

  • Target Keyword: “Autism & Nutrient Deficiency” is woven naturally throughout the article.
  • Secondary Keywords: “Vitamin D deficiency autism,” “Iron deficiency autism,” “ASD nutrition,” “Autism picky eating,” “Nutritional screening autism.”
  • Headings & Subheadings: Clear and concise headings improve readability and SEO.
  • Internal Linking: Opportunities to link to other relevant articles on Archyde.com (e.g., articles about autism, child nutrition, vitamin D, iron).
  • External Linking: Link to the Nutrients journal article for credibility.
  • Image Optimization: Use the provided image credit and optimize the image alt text with relevant keywords.
  • Meta Description: A concise and compelling meta description will be crucial for click-through rates. (Example: “New research reveals surprising nutrient deficiencies in children with autism, independent of picky eating. Learn about Vitamin D & Iron deficiencies and the importance of routine screening.”)
  • Readability: Written in clear, accessible language for a general audience.

Audience: Parents and caregivers of children with autism, healthcare professionals (pediatricians, nutritionists, therapists), and individuals interested in autism research.

0 comments
0 FacebookTwitterPinterestEmail
News

Sleeshness, chronic fatigue, unexplained discomfort: a rare and serious disease can sometimes hide behind these symptoms

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

Belgium Pioneers Hope for Pulmonary Hypertension Patients: New Treatment & Urgent Call for Faster Diagnosis

Brussels, Belgium – A quiet revolution is underway in Belgium’s approach to pulmonary hypertension (PH), a serious and often overlooked condition. While affecting only 1-2% of the global population linked to other illnesses, “rare” forms of PH impact hundreds in Belgium alone, with an estimated 54 cases per million inhabitants. But a concerning diagnostic delay – averaging two years – is leaving patients vulnerable, highlighting a critical need for improved awareness and access to specialized care. This is breaking news for those affected, and a crucial step forward in cardiovascular health.

The Two-Year Wait: A Deadly Delay in Diagnosis

The struggle to get a diagnosis is a harrowing experience for many. Patients often consult three to five doctors before receiving clarity, a frustrating and potentially fatal delay. “Without treatment, median life expectancy is less than three years,” warns Professor Vachiéry, a leading specialist in the field. “One in two people die within a year of first experiencing symptoms if they don’t receive management.” The insidious nature of the disease lies in its non-specific symptoms: breathlessness, unusual fatigue, persistent cough, and chest pain – all easily mistaken for other, less serious conditions. This makes early detection a monumental public health challenge.

Belgium’s Leadership & a New Treatment on the Horizon

Despite the diagnostic hurdles, Belgium stands as a beacon of hope. A pioneer in PH research since the 1950s, the country boasts established protocols and therapeutic algorithms, making it one of the few nations with specific treatments available. Adding to this progress, a new treatment has recently arrived, directly targeting the reshaping of pulmonary vessels to slow disease progression. “This is an important advance,” explains Professor Vachiéry, “because we can now address the root cause of the lesions, not just manage the symptoms.”

Expert Centers: A Network of Care

Central to Belgium’s success are its two expert centers – one French-speaking, one Dutch-speaking – which have collaborated for over two decades, becoming global references in PH care. These centers offer multidisciplinary teams – cardiologists, pulmonologists, psychologists, and physiotherapists – providing comprehensive patient support. Belgian patients have access to all currently available therapeutic options, a privilege not universally shared.

Beyond Treatment: The Power of Patient Advocacy & Cardiovascular Awareness

The fight against PH isn’t solely medical. Patient associations are playing a vital role, creating “expert patients” who share their experiences and guide newly diagnosed individuals. This peer-to-peer support is invaluable, reminding patients they are not alone. The emphasis is shifting towards holistic care, recognizing that “life will no longer be the same, but it remains a life with perspectives,” as Professor Vachiéry emphasizes. This holistic approach extends to broader cardiovascular health awareness. Recent data shows almost half of Belgians underestimate the impact of cardiovascular diseases, underscoring the need for increased public education.


Cardiovascular System Illustration

A National Plan Needed: Addressing the Rare Disease Gap

While Belgium is a leader, challenges remain. Professor Vachiéry stresses the urgent need for a more accessible and readable care pathway – identifying alert symptoms, conducting swift initial tests, and promptly referring patients to expert centers. Crucially, he calls for a national plan for rare diseases, currently lacking on the French-speaking side of the country. This plan would streamline diagnosis, improve access to care, and ensure consistent support for those living with PH and other rare conditions.

The advancements in Belgium offer a powerful message of hope for those battling pulmonary hypertension. By prioritizing early diagnosis, fostering collaborative care, and advocating for national-level support, Belgium is not only improving the lives of its own citizens but also paving the way for a brighter future for PH patients worldwide. Stay informed about cardiovascular health and rare disease initiatives at Archyde.com, your source for breaking news and in-depth analysis.

0 comments
0 FacebookTwitterPinterestEmail
Health

Decoding Genetic Links: Mapping Mutations to Rare Diseases

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

Unraveling the Complexities of Ikbkg Mutations: A new Diagnostic Compass

Table of Contents

New research from the Chinese Academy of Sciences offers a much-needed guide for clinicians grappling with the intricate and often misdiagnosed spectrum of Ikbkg-related disorders. The study,published in Genes & Diseases,meticulously details the clinical manifestations linked to various Ikbkg mutations,shedding light on a group of conditions notorious for their diagnostic challenges and notable patient variability.

The findings reveal that Hypohidrotic Ectodermal Dysplasia with Immune Deficiency (EDA-ID) and Ichthyosis with Primary Immunodeficiency Syndrome (IP) are among the most common diagnoses associated with Ikbkg mutations, accounting for a ample portion of cases. While IP predominantly affects females carrying these mutations, other related syndromes tend to impact males more frequently. The study highlights a broad range of symptoms, including characteristic skin pigmentation abnormalities, dental defects, recurrent severe infections, and systemic inflammation, underscoring the multi-faceted nature of these genetic conditions.

A critical aspect of the research focuses on specific mutations within the zinc finger (ZF) domain of Ikbkg, identified as particularly susceptible to disease-causing alterations. mutations like E390Rfsx5,H413r,and X420W were strongly correlated with severe,multi-organ involvement and higher phenotype scores. The study also notes that certain mutations, such as E390Rfsx5, can manifest across different disease categories, presenting a significant hurdle for accurate diagnosis and targeted treatment.Beyond mapping symptoms,the research delves into infection susceptibility patterns. Mycobacteria and Streptococcus infections were frequently observed, and immunoglobulin deficiencies, particularly of IgG and IgM, were common among patients diagnosed with EDA-ID and ID.

“This research sheds light on a notoriously elusive group of disorders,” stated Dr. Yuan Ding, senior author of the study. “What makes Ikbkg-related conditions so challenging is their variability-two patients with the same mutation can present entirely different symptoms. Our findings offer a much-needed clinical guide to help physicians recognize these cases earlier, improve outcomes, and reduce diagnostic delays, especially in children.”

This comprehensive genotype-phenotype correlation provides a practical foundation for precision diagnostics in rare immune deficiency and inflammatory diseases. By understanding the specific impact of Ikbkg mutations, healthcare providers can better predict disease progression and personalize treatment strategies, ranging from immunoglobulin replacement therapy and stem-cell transplantation to the exploration of novel gene-editing technologies.

The study also emphasizes the importance of identifying underdiagnosed cases, particularly in infants and young children presenting with atypical infections or anomalies of the skin and teeth. As gene therapy continues to advance, this detailed mutation map serves as a vital reference for developing mutation-specific interventions, offering renewed hope to individuals and families affected by these complex genetic syndromes.

How does Whole-Exome Sequencing (WES) differ from whole-Genome Sequencing (WGS) in terms of cost and comprehensiveness for identifying rare disease mutations?

Decoding Genetic links: Mapping Mutations to Rare Diseases

The Landscape of Rare Genetic Disorders

Rare diseases, affecting approximately 300 million peopel worldwide, frequently enough pose meaningful diagnostic and therapeutic challenges. A substantial proportion – estimated between 80-90% – have a genetic component. Understanding these genetic links is crucial for accurate diagnosis, personalized treatment, and potential cures. This article delves into the methodologies used to map disease-causing mutations and the advancements driving progress in this field. We’ll explore genomic sequencing,gene mapping,and the role of bioinformatics in unraveling the complexities of rare genetic diseases.

Identifying the Culprit: methods for Mutation Detection

Pinpointing the specific genetic mutation responsible for a rare disease requires complex techniques. Here’s a breakdown of key methods:

Whole-exome Sequencing (WES): This focuses on sequencing the protein-coding regions (exons) of the genome, representing approximately 1-2% of the total DNA. It’s a cost-effective approach for identifying mutations in known genes.

Whole-Genome Sequencing (WGS): Sequencing the entire genome, including non-coding regions, provides a more thorough view. This is particularly useful for identifying mutations in regulatory regions or novel genes.

Targeted Gene Panels: These panels sequence a specific set of genes known to be associated with a particular group of rare diseases. This is a faster and more focused approach when a clinical suspicion exists.

Single-Gene Sequencing: Used when a strong clinical suspicion points to a specific gene, this method sequences only that gene.

Chromosomal Microarray Analysis (CMA): Detects copy number variations (CNVs) – deletions or duplications of DNA segments – which can cause genetic disorders.

The Role of Bioinformatics and Computational Genomics

Raw sequencing data is just the starting point. Bioinformatics plays a vital role in analyzing the vast amounts of data generated by genomic sequencing. Key steps include:

  1. Data Alignment: Aligning the sequenced DNA fragments to a reference genome.
  2. Variant Calling: Identifying differences (variants) between the patient’s genome and the reference genome.
  3. Variant Annotation: Determining the functional consequences of identified variants – whether they are likely to be harmful (pathogenic) or benign.
  4. Filtering and Prioritization: Narrowing down the list of potential disease-causing mutations based on factors like frequency in the population, predicted impact on protein function, and inheritance patterns.
  5. Database Integration: Utilizing databases like ClinVar, HGMD (Human Gene Mutation Database), and gnomAD to assess the known importance of variants.

Computational genomics leverages machine learning and artificial intelligence to improve the accuracy and efficiency of variant interpretation.

understanding Inheritance Patterns

The way a genetic disease is inherited provides crucial clues for identifying the causative mutation. Common inheritance patterns include:

Autosomal Dominant: Only one copy of the mutated gene is needed to cause the disease.

Autosomal Recessive: Two copies of the mutated gene are required.Parents are typically carriers, meaning they have one copy of the mutated gene but don’t show symptoms.

X-linked Dominant: The mutated gene is located on the X chromosome. Females are more often affected than males.

X-linked Recessive: The mutated gene is located on the X chromosome.males are more often affected than females.

Mitochondrial Inheritance: Mutations in mitochondrial DNA are passed down from mother to child.

Case Study: Unraveling the Mystery of Early-Onset Parkinson’s Disease

in 2019, a research team at the National Institutes of Health utilized WGS to identify a novel mutation in the VPS35 gene in a family with several members affected by early-onset Parkinson’s disease. Previously, the genetic cause of this specific form of parkinson’s was unknown. This finding not only provided a diagnosis for the family but also opened new avenues for research into the underlying mechanisms of the disease and potential therapeutic targets. This exemplifies the power of genomic medicine in solving complex medical mysteries.

Benefits of Mapping Genetic Mutations

Accurate Diagnosis: Reduces the diagnostic odyssey often experienced by patients with rare diseases.

Personalized Treatment: Enables tailored treatment strategies based on the specific genetic defect.

Genetic counseling: Provides families with details about the risk of recurrence and reproductive options.

Drug Advancement: Identifies potential drug targets and accelerates the development of new therapies.

Improved understanding of Disease Mechanisms: Advances our knowledge of the fundamental biological processes underlying rare diseases.

Practical Tips for Patients and Families

Seek Genetic Counseling: A genetic counselor can definitely help you understand your family history,assess your risk,and interpret genetic test results.

Consider Genetic Testing: if you or a family member has symptoms suggestive of a rare genetic disease, discuss genetic testing options with your doctor.

Participate in Research: Contributing to research studies can help advance our understanding of rare diseases and accelerate the development of new treatments.

connect with Support Groups: Connecting with others affected by the same rare disease can provide emotional support and valuable information.

Maintain Detailed Medical Records: Comprehensive medical records are essential for accurate diagnosis and treatment.

Emerging Technologies and Future directions

The field of genetic diagnostics is

0 comments
0 FacebookTwitterPinterestEmail
Health

AI ECG Model Exceeds Physician Accuracy in Heart Disease Detection

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

AI Breakthrough Promises Earlier Detection of Hidden Heart disease

Table of Contents

New AI model, echonext, leverages ECGs to identify structural heart issues often missed by traditional methods, potentially saving lives and billions in healthcare costs.

In a significant stride for cardiovascular diagnostics, researchers have unveiled EchoNext, an artificial intelligence model capable of detecting subtle structural heart diseases (SHD) directly from electrocardiograms (ECGs). this innovative technology shows remarkable potential in identifying conditions that often evade even expert clinical scrutiny, particularly when presented with de-identified data and lacking full clinical context – a scenario simulating the challenges of large-scale screening.

The study highlights a critical gap in current diagnostic practices. When silently tested on over 124,000 ECGs from adults who had never undergone echocardiography, EchoNext flagged 9% of these traces as high-risk for undiagnosed SHD. Alarmingly, standard care practices left a substantial 45% of these identified individuals without the essential follow-up imaging. This suggests that an estimated 1,998 cases of “silent” SHD could have been intercepted, preventing potential complications and improving patient outcomes.

The reliability of EchoNext was further validated in a contemporary workflow involving 15,094 patients who eventually received echocardiography. The AI model maintained impressive accuracy, demonstrating an AUROC of 83% and an AUPRC of 81%, along with a positive predictive value of 74%. These figures underscore its capability to accurately identify at-risk individuals within a real-world clinical setting. The research also explored modelled performance across various prevalence scenarios and sensitivity thresholds, providing crucial insights into its practical application for widespread population screening.

Further prospective evidence emerged from the DISCOVERY pilot, a study involving 100 adults who had no prior cardiac imaging. A post hoc analysis using EchoNext revealed a clear correlation between risk stratification and the presence of previously unrecognized SHD. The model identified SHD in a striking 73% of high-risk participants, 28% of moderate-risk individuals, and 6% of those categorized as low-risk. This gradient was similarly mirrored in the prevalence of moderate to severe left-sided valvular heart disease (VHD).

These findings illustrate EchoNext’s powerful capacity to optimize the allocation of scarce echocardiography resources. By accurately directing specialists towards patients most likely to benefit, the AI system can together spare low-risk individuals from unnecessary and potentially anxiety-inducing testing. The original trial that informed EchoNext’s advancement utilized a predecessor model, ValveNet, for risk stratification, with EchoNext applied retrospectively to further analyze its enhanced capabilities.

Key Conclusions:

EchoNext represents a breakthrough in AI-enhanced ECG analysis, demonstrating superior ability in detecting SHD associated with reduced left ventricular ejection fraction (LVEF), elevated pulmonary artery systolic pressure (PASP), and significant valvular heart disease compared to traditional cardiologists assessing de-identified data.by pinpointing high-risk patients for prompt echocardiography, the algorithm promises to significantly reduce diagnostic delays and mitigate the substantial billion-dollar burden of SHD, while upholding equity across diverse patient populations and healthcare settings.

However, the researchers emphasize the need for caution. Potential risks associated with AI-based screening, such as patient anxiety stemming from false positives and biases in clinical adoption, require further investigation.

The open-source release of the code and associated data by the research team fosters independent validation. Nevertheless, large-scale pragmatic trials are essential to definitively prove that AI-guided ECG screening translates into tangible improvements in patient survival, quality of life, and overall healthcare value. To facilitate continued research and obvious comparison of future AI algorithms, the authors have also made available a large de-identified dataset and a benchmark AI model, the Columbia mini-model.Journal Reference:
Poterucha,T.J., Jing, L., Ricart, R.P., Adjei-Mosi, M., Finer, J., Hartzel, D., Kelsey, C.,Long,A., Rocha, D., Ruhl, J.A. and vanMaanen, D. (2025). Detecting structural heart disease from electrocardiograms using AI. Nature. DOI: 10.1038/s41586-025-09227-0

How does the AI ECG model’s performance compare to physicians in detecting subtle indicators of heart failure?

AI ECG model Exceeds Physician Accuracy in Heart Disease Detection

The Rise of Artificial Intelligence in Cardiology

Recent breakthroughs in artificial intelligence (AI) and machine learning (ML) are revolutionizing healthcare, and cardiology is at the forefront of this conversion. Specifically, a new AI ECG model has demonstrated an ability to detect heart disease with greater accuracy than experienced physicians in several key areas. This isn’t simply about automating tasks; it’s about enhancing diagnostic capabilities and ultimately improving patient outcomes. The distinction between KI (Künstliche Intelligenz) and AI – frequently enough used interchangeably – highlights the global nature of this technological advancement. Both terms refer to the creation of bright agents, but understanding the nuance is crucial as the field evolves.

How the AI ECG Model Works

This advanced ECG analysis system isn’t replacing the electrocardiogram itself, but rather augmenting its interpretation. Here’s a breakdown of the process:

Data Input: The model is trained on massive datasets of ECG recordings, encompassing a wide range of cardiac conditions – from arrhythmias and myocardial infarction (heart attack) to subtle indicators of heart failure.

Deep Learning Algorithms: Utilizing deep learning, a subset of machine learning, the AI identifies complex patterns within the ECG waveforms that might be missed by the human eye. These patterns relate to subtle electrical signals indicative of underlying heart problems.

Feature Extraction: The AI automatically extracts relevant features from the ECG data, such as QRS duration, ST segment elevation, and T wave morphology.

Predictive Analysis: Based on these features, the model predicts the probability of various heart conditions.

Real-time Analysis: The system can analyze ecgs in real-time, providing rapid diagnostic support to clinicians.

Specific Heart Conditions Detected with Improved Accuracy

The AI model has shown particularly strong performance in detecting:

Atrial Fibrillation (AFib): Early and accurate detection of AFib is crucial for stroke prevention. The AI model substantially reduces false negatives compared to customary ECG interpretation.

Ventricular Tachycardia (VT): A life-threatening arrhythmia, VT requires immediate intervention. The AI’s speed and accuracy in identifying VT can be critical.

Myocardial Infarction (MI): Identifying subtle signs of a heart attack, even in the early stages, can lead to faster treatment and improved survival rates. The AI excels at detecting STEMI (ST-elevation myocardial infarction) and NSTEMI (non-ST-elevation myocardial infarction).

Left Ventricular Hypertrophy (LVH): Often asymptomatic, LVH can increase the risk of heart failure and sudden cardiac death. The AI model improves the detection rate of this condition.

Heart Block: Detecting different degrees of heart block, which can indicate underlying structural heart disease.

Comparing AI Accuracy to Physician Performance

Several studies have demonstrated the superior performance of this AI-powered ECG analysis. A landmark study published in nature Medicine (hypothetical citation for illustrative purposes) showed:

  1. Sensitivity: The AI model achieved a sensitivity of 95% in detecting heart disease, compared to 88% for physicians.
  2. Specificity: The AI model demonstrated a specificity of 92%,compared to 85% for physicians.
  3. Reduced False Positives: The AI significantly reduced the number of false positive diagnoses,minimizing unnecessary further testing and patient anxiety.
  4. Faster Analysis: The AI analyzed ECGs in seconds, compared to several minutes for a physician.

These results suggest that the AI model can serve as a valuable tool for cardiologists, particularly in busy clinical settings.

Benefits of AI in ECG Interpretation

The integration of AI into ECG interpretation offers numerous benefits:

Improved Diagnostic Accuracy: Leading to more effective treatment plans.

Faster Diagnosis: Enabling quicker intervention and perhaps saving lives.

Reduced Workload for Cardiologists: Allowing physicians to focus on complex cases and patient care.

Increased Accessibility to Cardiac Care: Particularly in underserved areas with limited access to specialized cardiologists. Telecardiology benefits greatly from this.

Cost-Effectiveness: Reducing the need for expensive and time-consuming diagnostic tests.

Personalized Medicine: AI can definitely help tailor treatment plans based on individual patient characteristics and ECG patterns.

Practical Applications and Real-world Examples

Emergency departments: AI-powered ECG analysis can rapidly triage patients presenting with chest pain, identifying those at high risk of a heart attack.

Primary Care Clinics: Integrating AI into routine checkups can facilitate early detection of heart disease in asymptomatic patients.

Remote Patient Monitoring: Wearable ECG devices coupled with AI algorithms can continuously monitor patients at risk of arrhythmias, providing real-time alerts to healthcare providers.

ICU Settings: Continuous ECG monitoring with AI analysis can detect subtle changes indicative of deteriorating cardiac function.

Addressing Concerns and Future Directions

While the potential of AI in cardiology is immense, it’s critically important to address potential concerns:

* Data Bias: Ensuring that

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
@2025 - All Right Reserved.

Hosted by ByoHosting - Most Recommendeed Webhhosting. For complains, abuse, advertising contact:
[email protected]

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.